Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ImageneBioIMA +0.36%10 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates IMA with a GF Score™ of 10/100. The stock has 3 warning signs investors should review. Among 949 Biotechnology companies, ImageneBio ranks worse than 85.77% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ImageneBio's Free Cash Flow for the
three
months ended in Mar. 2026 was $-14.80 Mil. ImageneBio's Revenue for the
three
months ended in Mar. 2026 was $0.00 Mil. Therefore, ImageneBio's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for ImageneBio's FCF Margin % or its related term are showing as below:
IMA'
s FCF Margin % Range Over the Past 10 Years
Min: -5980.5 Med: -609.11 Max: -232.83
Current: -2752.25
During the past 3 years, the highest FCF Margin % of ImageneBio was -232.83%. The lowest was -5980.50%. And the median was -609.11%.
IMA's FCF Margin % is ranked worse than 85.77% of 949
companies
in the Biotechnology industry
Industry Median: -82.65
vs IMA: -2752.25
ImageneBio FCF Margin % Related Terms
ImageneBio FCF Margin % Historical Data
* Premium members only.
The historical data trend for ImageneBio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, ImageneBio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ImageneBio FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ImageneBio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where ImageneBio's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ImageneBio (IMA) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ImageneBio and its competitors. According to the industry distribution chart, ImageneBio ranks #814 out of 949 companies in the Biotechnology industry, placing it in the top 85.8%.
Is ImageneBio's FCF Margin % too high?
ImageneBio's current FCF Margin % is 0.00%. Based on the distribution chart, ImageneBio ranks #814 out of 949 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ImageneBio has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does ImageneBio's FCF Margin % compare to HYFT and CING?
According to the Biotechnology industry distribution chart, ImageneBio ranks #814 out of 949 companies for FCF Margin %. This places ImageneBio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ImageneBio and its competitors. ImageneBio's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ImageneBio stock overvalued right now?
ImageneBio (IMA) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. ImageneBio's overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For ImageneBio (IMA), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
10GF Score
Get the complete analysis for IMA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IMA has been successfully added to your 
